Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level650 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01534546 | Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | unknown | Phase 3 | 1,094 | Peking UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | completed | Phase 2 / Phase 3 | 716 | Krankenhaus NordwestOTHER |
| 1 |
| Jun 19, 2019 |
| clinicaltrials |
| NCT03941561 | S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） | recruiting | Phase 3 | 1,006 | Fudan UniversityOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT03961373 | Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer(Neo-D2plus) | recruiting | Phase 3 | 539 | University of SienaOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT02736552 | Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. | withdrawn | Phase 3 | 0 | Fudan UniversityOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT03654534 | Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy | unknown | Phase 3 | 374 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT02647476 | Postoperative Enteral Immunonutrition in Gastric Cancer | completed | Phase 3 | 98 | Jagiellonian UniversityOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02490111 | Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer | completed | Phase 3 | 521 | Daewoong Pharmaceutical Co. LTD.INDUSTRY | 1 | Feb 8, 2019 | clinicaltrials |
| NCT03350477 | Bioinformation Therapy for Gastric Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT01824459 | S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients | completed | Phase 3 | 576 | Sun Yat-sen UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02120885 | An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial(Gastric cancer) | completed | Phase 3 | 70 | Yonsei UniversityOTHER | 1 | Jan 22, 2019 | clinicaltrials |
| NCT01065688 | A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer | completed | Phase 3 | 120 | Wakayama Medical UniversityOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT03680261 | Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy | unknown | Phase 3 | 556 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT03598348 | Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer | unknown | Phase 3 | 288 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03601988 | Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer | unknown | Phase 3 | 408 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT02706184 | E. Coli Nissle in Oncology(EcNO) | completed | Phase 3 | 20 | University of HohenheimOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT02150447 | The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding | terminated | Phase 3 | 394 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 4, 2018 | clinicaltrials |
| NCT01813253 | Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer | terminated | Phase 3 | 400 | Kuhnil Pharmaceutical Co., Ltd.INDUSTRY | 3 | Mar 26, 2018 | clinicaltrials |
| NCT03475615 | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites | unknown | Phase 3 | 215 | Fudan UniversityOTHER | 1 | Mar 23, 2018 | clinicaltrials |
| NCT01683864 | Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer(HIPECStomach) | terminated | Phase 2 / Phase 3 | 3 | University Hospital TuebingenOTHER | 1 | Jan 30, 2018 | clinicaltrials |
| NCT02110628 | Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy(WCGCC-1202) | unknown | Phase 3 | 588 | West China HospitalOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT03399253 | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor | unknown | Phase 2 / Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT02461407 | Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) | unknown | Phase 2 / Phase 3 | 378 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 29, 2017 | clinicaltrials |
| NCT03355612 | XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma | unknown | Phase 3 | 456 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 28, 2017 | clinicaltrials |
| NCT02356276 | Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2(EHTLAGCRGD2) | unknown | Phase 3 | 584 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT00407186 | Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) | unknown | Phase 3 | 788 | Dutch Colorectal Cancer GroupOTHER | 1 | Oct 10, 2017 | clinicaltrials |
| NCT02509806 | Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02510469 | Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03223740 | Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy(President) | unknown | Phase 3 | 450 | Sichuan Provincial People's HospitalOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT03179579 | Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer | unknown | Phase 3 | 88 | Shu-Zhong CuiOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT01641939 | A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | terminated | Phase 2 / Phase 3 | 415 | Hoffmann-La RocheINDUSTRY | 28 | May 12, 2017 | clinicaltrials |
| NCT03117023 | The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer | unknown | Phase 3 | 50 | Nanjing PLA General HospitalOTHER | 0 | Apr 17, 2017 | clinicaltrials |
| NCT00887822 | A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer(AVATAR) | completed | Phase 3 | 202 | Hoffmann-La RocheINDUSTRY | 1 | Mar 1, 2017 | clinicaltrials |
| NCT01099085 | Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients | completed | Phase 3 | 207 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02780921 | Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial(PREHAB) | unknown | Phase 3 | 120 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT01433861 | Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy(PRAPT) | terminated | Phase 3 | 7 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT02748551 | A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer | unknown | Phase 3 | 800 | Moscow Clinical Scientific CenterOTHER | 2 | Dec 13, 2016 | clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT02980861 | Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection | unknown | Phase 3 | 200 | Chinese PLA General HospitalOTHER | 1 | Dec 6, 2016 | clinicaltrials |
| NCT01450696 | A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer(HELOISE) | terminated | Phase 3 | 296 | Hoffmann-La RocheINDUSTRY | 25 | Nov 28, 2016 | clinicaltrials |
| NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | completed | Phase 3 | 564 | Hoffmann-La RocheINDUSTRY | 24 | Nov 2, 2016 | clinicaltrials |
| NCT02560974 | A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer | completed | Phase 3 | 1,035 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | completed | Phase 3 | 316 | Hoffmann-La RocheINDUSTRY | 14 | Nov 2, 2016 | clinicaltrials |
| NCT01795027 | Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer(CAPITAL) | unknown | Phase 3 | 724 | Sun Yat-sen UniversityOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | completed | Phase 3 | 690 | Japan Clinical Oncology GroupOTHER | 1 | Sep 12, 2016 | clinicaltrials |
| NCT02537171 | Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer | unknown | Phase 3 | 40 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT02817425 | A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 300 | LanZhou UniversityOTHER | 1 | Jun 29, 2016 | clinicaltrials |
| NCT00216034 | Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK | completed | Phase 3 | 255 | Hokuriku-Kinki Immunochemotherapy Study GroupOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT02784470 | Study of Gastroduodenal Metallic Stent vs Gastrojejunostomy | unknown | Phase 3 | 92 | Asan Medical CenterOTHER | 1 | May 27, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Sep 17, 2019source: clinicaltrials